| ID |
Reference |
Source Clone name |
Sequence |
Motif |
Target-tumor |
Target-cell |
Receptors-biomarker |
Phage/Library |
In vitro/Ex-vivo |
In vivo |
Homing/targeting |
Payloads |
Patent |
| 1014 | Zhi M et al. Chin Med J (Engl). 2011 Feb;124(4):581-5. | NA | CNRRTKAGC | NA | Esophagus and gastroesophageal cancer | Tumor vessel | NA | M13 phage/C7C peptide library | NA | 2-month-old Balb/c mice with human esophageal tumor xenograft, fresh human esophageal cancer tissue in immunosuppressed Balb/c mice | Homing | NA | NA |
| 1206 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | Ph12-1 | WNLPWYYSVSPT | LTVXPW | Breast cancer | NA | NA | M13 phage/ 12 mer peptide library&M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3, T47D, MCF-7, PM-, colon cancer cell line HT2933,prostate cancer cell line DU145; lung cancer cell line DMS-273,U87MG cell line, | NA | Targeting | GFP & 6-iodoacetamido | NA |
| 1207 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVLPW | LTVXPW | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1208 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVEPWL | LTVXPW | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1209 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVSPLWD | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1210 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVTPWL | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1211 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVQPWP | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1212 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVSPWT | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1213 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | VLTVQPW | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1214 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTVSLWT | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1215 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | PGVIPWN | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1216 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | LTYQTWP | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1217 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | ELYVSRL | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1218 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | NLYYASW | NA | Breast carcinoma | NA | Podoplanin, Prox-1, LYVE-1 and VGFR3 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | Fluorescein | NA |
| 1219 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | GFP-peptide fusion proteins | LTVSPWY | NA | Breast cancer | Tumor cell | ErbB2 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3, T47D, PM1,HT2933. | NA | Targeting | GFP | NA |
| 1220 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | TLTVLPW | NA | Breast cancer | Tumor cell | ErbB2 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | NA | NA |
| 1221 | Shadidi M et al. FASEB J. 2003 Feb;17(2):256-8. | NA | NLYVASW | NA | Breast cancer | Tumor cell | ErbB2 | M13 phage/7 mer peptide library | The breast cancer cell lines SK-BR-3 | NA | Targeting | NA | NA |
| 1222 | Arap W et al. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1527-31. | Chimeric SMSIARL-GG-D(KLAKLAK)2 | SMSIARL | NA | Prostrate cancer | Angiogenic endothelial cell | NA | T7,fUSE5 phage /7mer peptide library | NA | TRAMP (prostate cancer-prone transgenic mice),CD-1 male mice (2-4 months) | Homing | Proapoptotic peptide (KLAKLAK)2 | US 2001/0046498 A1 |
| 1223 | Arap W et al. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1527-31. | NA | VSFLEYR | NA | Prostrate cancer | NA | NA | T7,fUSE5 phage /7mer peptide library | NA | CD-1 male mice(2-4 months) | Homing (Phage display clone) | NA | US 6,232,287 B1 |
| 1224 | Essler M et al. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2252-7. | NA | CPGPEGAGC | NA | Breast cancer | Blood vessel | Membrane-bound proline-specific aminopeptidase P | T7 phage/ CX7C peptide library | NA | Malignant lesions in transgenic breast cancer miceMMTV PyMT mice, CD mice . | Homing | NA | WO02099379A2 |
| 1225 | Janssen ML et al. Cancer Res. 2002 Nov 1;62(21):6146-51. | Dimeric RGD peptide | RGDfK | RGD | Growing tumor | Endothelial cell | Alpha-5 beta -3 integrins | NA | NA | BALB/c mice bearing ovarian carcinoma xenograft | Homing | Indium111 | US 2003/0125243 A1 |
| 1226 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | PRPGAPLAGSWPGTS | PRP | Melanoma, Pancreatic, Brain cancer | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | Human tumor tissues of islet cells of pancreas, glioblastoma of brain. | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells | Homing | Radionuclide PRP-Lip -Andramycin drug | EP1122262A4 |
| 1227 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | ADGAPRPGAPLA | PRP | Melanoma | Angiogenic endothelial cell | VEGF | NA | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing | NA | NA |
| 1228 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | DRWRPALPVVLFPLH | WRP | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing | NA | US 6,753,310 B1 |
| 1229 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | ASSSYPLIHWRPWAR | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing | NA | US 6,753,310 B1 |
| 1230 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | DRWRPALP | WRP | Melanoma | Angiogenic endothelial cell | VEGF | NA | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing | NA | NA |
| 1231 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | IHWRPWAR | WRP | Melanoma | Angiogenic endothelial cell | VEGF-C | NA | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing | NA | NA |
| 1232 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | AAEWLDAFFVRHVDR | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | US 6,753,310 B1 |
| 1233 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | GDVWLFLTSTSHFAR | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | US 6,753,310 B1 |
| 1234 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | GCSVSSVGALCTHV | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | NA |
| 1235 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | APCCSHLDASPFQRP | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | US 6,753,310 B1 |
| 1236 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | AQSNFVTWGYNVAV | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | NA |
| 1237 | Oku N et al. Oncogene. 2002 Apr 18;21(17):2662-9. | NA | RASDVGSDVVPRYPF | NA | Melanoma | Angiogenic endothelial cell | VEGF | M13 phage/15 mer peptide library | NA | 5-week-old C57BL/6 male bearing B16BL6 melanoma cells derived tumor | Homing (Phage display clone) | NA | US 6,753,310 B1 |
| 1496 | NA | NA | CVPELGHEC | NA | Ovarian cancer | NA | NA | T7 phage / 9-mer cyclic peptides (CX7C) | Patient serum | NA | Targeting | NA | US20040048243 A1 |